You’re saying this but if that’s the case why hasn’t SNS/CEL gone all mainstream
?
I might be wrong, but I’d imagine their profit margins on skus like anabeta Elite, alpha t2, etc were/are higher than their profit margins on proteins.
Better profit margins don't always equal more profit. Things like demand and production to sales ratios play a huge factor in profit and can explain a product like ABE being discintinued. For instance and this is not exact numbers associated with PEScience products just an example for reference.
Lets say product A costs 12 dollars to produce and sells for 15 dollars. We produce 11000 units of product A of which 10800 are sold prior to expiration. That would be 10,800X3 or 32,400 in profit and 12X200 or 2400 in losses from expired product that does not sell. Equalling a total profit of 30,000.
Now we have product B that costs 19 dollars to produce and sells for 20. We produce 70,000 units of which all 70,000 not only sell but fly off the shelf showing us it would not be a gamble to increase production and focus our attention on expaninding this products availability and variety. That would equal 70,000 in profit and a very minimal risk in continuing and increasing production of Product B.
Not true examples of our products profit or price scale but just a bit of an idea of what factors would come in to play when making a decision that may not be the most popular but just make sense.
ABE contains ingredients that are not exactly cheap to source so playing a guessing game on production quantities when our company has expanded and grown so much could easily be a game of russian roulette if we continue to produce a product that just isn't getting the sales we would anticipate or need to justify keeping it in our product line.
I hope this helps to explain and unfortunately like the others expressing their concern I wish ABE would have sold out more frequently because as I mentioned it was my go to for many reasons.
jk....hopefullyjk....hopefully
